TY - JOUR
T1 - Krüppel-like factor 4 (KLF4) regulates the miR-183~96~182 cluster under physiologic and pathologic conditions
AU - Segura, Miguel F.
AU - Jubierre, Luz
AU - Li, Si De
AU - Soriano, Aroa
AU - Koetz, Lisa
AU - Gaziel-Sovran, Avital
AU - Masanas, Marc
AU - Kleffman, Kevin
AU - Dankert, John F.
AU - Walsh, Martin J.
AU - Hernando, Eva
N1 - Funding Information:
This work was supported by NCI/NIH Grant (5R01CA155234), Instituto de Salud Carlos III (CP11/00052 and RD12/0036/0016) co-financed by the European Regional Development Fund (ERDF), and European Commission's Framework Programme 7 through the Marie Curie Career Integration Grants. The authors thank Dr. Dorothy Bennett (UCL) for kindly providing us with human immortal melanocytes (Hermes) and Dr. Alan Houghton (MSKCC) for some of the SK-MEL cell lines.
PY - 2017
Y1 - 2017
N2 - MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs that posttranscriptionally control the translation and stability of target mRNAs in a sequencedependent manner. MiRNAs are essential for key cellular processes including proliferation, differentiation, cell death and metabolism, among others. Consequently, alterations of miRNA expression contribute to developmental defects and a myriad of diseases. The expression of miRNAs can be altered by several mechanisms including gene copy number alterations, aberrant DNA methylation, defects of the miRNA processing machinery or unscheduled expression of transcription factors. In this work, we sought to analyze the regulation of the miR-182 cluster, located at the 7q32 locus, which encodes three different miRNAs that are abundantly expressed in human embryonic stem cells and de-regulated in cancer. We have found that the Krüppel-like factor 4 (KLF4) directly regulates miR-182 cluster expression in human embryonic stem cells (hESCs) and in melanoma tumors, in which the miR-182 cluster is highly expressed and has a pro-metastatic role. Furthermore, higher KLF4 expression was found to be associated with metastatic progression and poor patient outcome. Loss of function experiments revealed that KLF4 is required for melanoma cell maintenance. These findings provide new insights into the regulation of the miR-182 cluster expression and new opportunities for therapeutic intervention in tumors in which the KLF4-miR-182 cluster axis is deregulated.
AB - MicroRNAs (miRNAs) are a class of endogenous non-coding small RNAs that posttranscriptionally control the translation and stability of target mRNAs in a sequencedependent manner. MiRNAs are essential for key cellular processes including proliferation, differentiation, cell death and metabolism, among others. Consequently, alterations of miRNA expression contribute to developmental defects and a myriad of diseases. The expression of miRNAs can be altered by several mechanisms including gene copy number alterations, aberrant DNA methylation, defects of the miRNA processing machinery or unscheduled expression of transcription factors. In this work, we sought to analyze the regulation of the miR-182 cluster, located at the 7q32 locus, which encodes three different miRNAs that are abundantly expressed in human embryonic stem cells and de-regulated in cancer. We have found that the Krüppel-like factor 4 (KLF4) directly regulates miR-182 cluster expression in human embryonic stem cells (hESCs) and in melanoma tumors, in which the miR-182 cluster is highly expressed and has a pro-metastatic role. Furthermore, higher KLF4 expression was found to be associated with metastatic progression and poor patient outcome. Loss of function experiments revealed that KLF4 is required for melanoma cell maintenance. These findings provide new insights into the regulation of the miR-182 cluster expression and new opportunities for therapeutic intervention in tumors in which the KLF4-miR-182 cluster axis is deregulated.
KW - Embryonic stem cells
KW - KLF4
KW - Melanoma
KW - MiR-183~96~182 cluster
KW - MicroRNA
UR - http://www.scopus.com/inward/record.url?scp=85017506314&partnerID=8YFLogxK
U2 - 10.18632/oncotarget.15459
DO - 10.18632/oncotarget.15459
M3 - Article
AN - SCOPUS:85017506314
SN - 1949-2553
VL - 8
SP - 26298
EP - 26311
JO - Oncotarget
JF - Oncotarget
IS - 16
ER -